skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: AI system may accelerate search for cancer discoveries

AI system may accelerate search for cancer discoveries

29 November 2018

AI system may accelerate search for cancer discoveries Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system. The system, called LION LBD and developed by computer scientists and cancer researchers at the University of Cambridge, has been designed to...


Read more at: Microsoft to support AI research at Cambridge University

Microsoft to support AI research at Cambridge University

5 November 2018

The University of Cambridge is teaming up with Microsoft to tackle the problem of 'brain drain' in AI and machine learning research. The software giant will help increase AI research capacity and capability at Cambridge by supporting visiting researchers, postdoctoral researchers, PhD students and interns from the UK, EU...


Read more at: 3D ‘organ on a chip’ could accelerate search for new disease treatments

3D ‘organ on a chip’ could accelerate search for new disease treatments

31 October 2018

Researchers have developed a three-dimensional ‘organ on a chip’ which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research. Two-dimensional cell models have served the scientific community well, but we now need to...


Read more at: Many cases of dementia may arise from non-inherited DNA ‘spelling mistakes’

Many cases of dementia may arise from non-inherited DNA ‘spelling mistakes’

18 October 2018

Many cases of dementia may arise from non-inherited DNA ‘spelling mistakes’ Only a small proportion of cases of dementia are thought to be inherited – the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications , a team of scientists led by researchers at the University...


Read more at: Targeting hard-to-treat cancers

Targeting hard-to-treat cancers

17 October 2018

Cambridge leads a £10 million interdisciplinary collaboration to target the most challenging of cancers. We are going to pierce through the body’s natural barriers and deliver anti-cancer drugs to the heart of the tumour. George Malliaras While the survival rate for most cancers has doubled over the past 40 years, some...


Read more at: Professor Sir Greg Winter wins the 2018 Nobel Prize in Chemistry

Professor Sir Greg Winter wins the 2018 Nobel Prize in Chemistry

3 October 2018

Professor Sir Greg Winter, of the University of Cambridge, has been jointly awarded the 2018 Nobel Prize in Chemistry along with Frances Arnold and George Smith for his pioneering work in using phage display for the directed evolution of antibodies, with the aim of producing new pharmaceuticals. It came as a bit of a shock...


Read more at: Mitochondrial diseases could be treated with gene therapy, study suggests

Mitochondrial diseases could be treated with gene therapy, study suggests

27 September 2018

Mitochondrial diseases could be treated with gene therapy, study suggests Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people. One idea for treating these devastating diseases is to reduce the amount of...


Read more at: Scientists reveal plan to target the cause of Alzheimer’s disease

Scientists reveal plan to target the cause of Alzheimer’s disease

27 September 2018

Scientists reveal plan to target the cause of Alzheimer’s disease Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease. This is the first time that a systematic method to go after the pathogens – the cause of Alzheimer’s disease - has been proposed -...


Read more at: New research facility for neurodegenerative disorders opened in Cambridge

New research facility for neurodegenerative disorders opened in Cambridge

27 September 2018

The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge. The building houses the Centre for Misfolding Diseases, a world-leading research...


Read more at: Bereavement triggers development of low-cost AI heart monitor

Bereavement triggers development of low-cost AI heart monitor

18 September 2018

A Cambridge startup has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time. Cambridge Heartwear hopes to use its wireless monitor to improve detection of irregular and dangerous heart rhythms and reduce the...